Riskpilot← Back to searchSign inGet full accessNovoxy Scandinavia AB
ABActiveOrg 5564392602Ringvägen 156Business and other management consultancy activities · NACE 7020Est. 19910 employees
Revenue 2024
SEK 0
EBITDA margin
—
-1321% vs 2023
Equity ratio
83.2%
Financial strength
Net profit 2024
SEK 101K
-57% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -199K | -1321% |
| Net profit | SEK 101K | -57% |
| Total assets | SEK 1,1M | +3% |
| Equity | SEK 935K | -14% |
| Employees | 0 | — |
Legal name
Novoxy Scandinavia AB
Org number
5564392602
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
16 december 1991
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall själv eller genom dotterföretag driva verksamhet med konsulttjänster inom marknadföring, affärsutveckling, luftmiljö, inredning och event, import och export och försäljning av produkter inom hälsa och luftmiljö såsom luftrenare, produkter inom inredning speciellt glasmosaik och kakel samt köp och försäljning av fast och lös egendom, företrädesvis värdepapper. Bolaget kan även bedriva annan verksamhet som är förenlig med den verksamhet som framgår av första meningen.
Address
Ringvägen 156
Email
tove@bizone.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −11 | −12 | −13 | −14 | −199 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −11 | −12 | −13 | −14 | −199 |
| Net financials | 1 300 | 250 | 250 | 250 | 65 |
| Profit before tax | 1 388 | 238 | 237 | 236 | 101 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 1 388 | 238 | 237 | 236 | 101 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 133 | 1 116 | 1 103 | 1 094 | 1 124 |
| Equity | 2 122 | 1 110 | 1 097 | 1 084 | 935 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 11 | 6 | 6 | 11 | 188 |
| Total debt | 11 | 6 | 6 | 11 | 188 |
EBITDA margin
-19900000.0%
This company
15.8%
Market median
-125949467% vs market
20202024
Equity ratio
83.2%
This company
38.2%
Market median
+118% vs market
20202024
Return on equity
10.8%
This company
18.4%
Market median
+41% vs market
20202024
Net profit margin
10100000.0%
This company
8.1%
Market median
+124691258% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.20×
This company
0.62×
Market median
+68% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
HH Audit | Audit | 2020 |
AT Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2020 | |
| Chairman | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Novoxy Scandinavia AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hans Henric Larsolle | Audit | 0 companies |
| Anne Tove Ellen Ederstål | Deputy Chief Executive Officer | 0 companies |
| Kim Ellen Maesel | Deputy Board Member | 0 companies |
| Pär Anders Ederstål | Chairman | 0 companies |